A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.
Aparicio AM, Tidwell RSS, Yadav SS, Chen JS, Zhang M, Liu J, Guo S, Pilié PG, Yu Y, Song X, Vundavilli H, Jindal S, Zhu K, Viscuse PV, Lebenthal JM, Hahn AW, Soundararajan R, Corn PG, Zurita-Saavedra A, Subudhi SK, Zhang J, Wang W, Huff C, Troncoso P, Allison JP, Sharma P, Logothetis CJ.
Aparicio AM, et al. Among authors: viscuse pv.
Clin Cancer Res. 2024 Jul 1;30(13):2751-2763. doi: 10.1158/1078-0432.CCR-23-3740.
Clin Cancer Res. 2024.
PMID: 38683200
Clinical Trial.